Chronic News and Research

RSS

Kent State University receives four-year, $2.7M grant to study cognitive status of heart failure patients

The National Institutes of Health has awarded a $2.7-million grant to Kent State University for a collaborative research project with Case Western Reserve University School of Nursing, Summa Health System in Akron and University Hospitals Case Medical Center in Cleveland to study cognitive impairment in heart failure patients.

7 May 2010

NewCardio to unveil patented CardioBip technology at HRS Annual Scientific Sessions

NewCardio, Inc., a cardiac diagnostic technology provider, will unveil its patented CardioBip technology for remote wireless 12-lead detection and monitoring of atrial fibrillation, ischemia and other cardiovascular events at the Heart Rhythm Society 31st Annual Scientific Sessions, May 12-15, 2010, in Denver, Colorado.

7 May 2010

First 3-year results of world's largest temporomandibular joint disorder study reported at APS meeting

Scientists with the University of Maryland Dental School and collaborators at three other major universities will report results from the first three years of the world's largest study yet of a mysterious yet common pain syndrome involving the jaw at 8:30 a.m.on May 7 at the annual scientific meeting of the American Pain Society (APS). This year it is being held at the Baltimore Convention Center.

7 May 2010

Cytori Therapeutics to initiate European medical device approval study for Celution System

The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells for the treatment of heart attacks showed a substantial reduction in the size of injury to the heart, an improvement in the amount of blood supply to the heart muscle, and a corresponding functional improvement in the amount of blood the heart can pump.

7 May 2010

New research examines coping and appraisal of disease-related pain

Growing evidence suggests how individuals cope with and appraise disease-related pain, such as arthritis or cancer, is related not only to their experience with pain but also to their physical and psychological functioning, according to new research presented here today in a plenary session talk at the American Pain Society's annual scientific meeting.

7 May 2010

Inadvertent reprogramming of genes in peripheral nervous system may cause chronic pain

Chronic pain severely limits patients' quality of life and is among the cost drivers in U.S. health care. Patients can suffer pain without an apparent cause and often fail to respond to available treatments. Mayo Clinic researchers and collaborators now report that chronic pain may be caused by the inadvertent reprogramming of more than 2,000 genes in the peripheral nervous system. The research findings appear in the current issue of the journal Genome Research.

7 May 2010

Meda acquires exclusive rights for use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals

Meda has acquired exclusive US, Canadian and Japanese rights for the use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals. As part of the agreement, Meda is taking over full responsibility for development and commercialization of the compound. Flupirtine is currently in phase II development for the patented indication fibromyalgia.

7 May 2010

Advances in genetic research could help develop personalized pain medications

In the not too distant future, it may be possible to discern an individual's genetic predisposition to chronic pain conditions and treat them proactively to prevent lifetime afflictions, according to research presented today at the American Pain Society's (www.ampainsoc.org) annual scientific meeting.

7 May 2010

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced the presentation of data on its novel resolvins for the treatment of both ocular surface diseases and retinal diseases at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida, being held May 2-6, 2010.

7 May 2010

Hepcidin is found in various biological fluids, says new research

Recent studies have highlighted the importance of hepcidin in iron metabolism, particularly anaemia of chronic disease and iron overload. There have also been reports of its expression in various proinflammatory disorders and various organs, linking it to innate immunity and iron metabolism.

7 May 2010

Medtronic initiates U.S. clinical trial of RestoreSensor neurostimulator in chronic pain patients

Medtronic, Inc. today announced the initiation of a prospective, multi-center, randomized U.S. clinical trial for the RestoreSensorTM neurostimulator that adapts therapy to the changing needs of chronic pain patients by responding automatically to changes in body position and activity in an upright position.

7 May 2010

Telik first-quarter net loss decreases to $5.3 million

Telik, Inc. today reported financial results for the first quarter ended March 31, 2010. The net loss for the quarter ended March 31, 2010 was $5.3 million, or $0.10 per share, compared with a net loss of $7.7 million, or $0.14 per share, for the same period in 2009.

7 May 2010

Study analyzes epidemiology of falls among elderly men

Falls and fall prevention are a major concern for the elderly and people with osteoporosis, a common chronic disease which causes weak and fragile bones. People with osteoporosis are at increased risk of fracture, even after a minor fall from standing height.

7 May 2010

Tel Aviv researchers develop microscope-based cell scanner to speed research into fat-busting drugs

Anglers rely on fish finders to help them locate the big catch. Now Tel Aviv University researchers in tissue engineering have developed a "fat finder" that can help scientists accelerate their research into new fat-melting drugs.

7 May 2010

Australia’s first ever health policy for men

Prime Minister Kevin Rudd yesterday announced Australia’s first ever men’s health policy called the “National Male Health Policy”. He said in the announcement during a visit to the Whittlesea Men's Shed in Victoria, “They either think that they're invincible that they can just tough it out…'They don't like talking about it usually, and frankly, the problem with all that is it makes it really hard to deal with men's health problems before they become too serious.” He felt this move was long due. He added, “'It's a pretty important time that we do that, we're probably about 110 years late.”

6 May 2010

PurGenesis announces positive results from Phase I clinical trial of PUR0110 for ulcerative colitis

PurGenesis Technologies Inc. announced today positive results from a Phase I clinical trial on PUR0110, the Company's lead investigational new drug for the treatment of ulcerative colitis. This successful trial was designed to evaluate the safety and maximum tolerated dose of PUR0110.

6 May 2010

CombinatoRx reports $41.3M total revenue for first-quarter 2010

CombinatoRx, Incorporated today reported financial results for the first quarter ended March 31, 2010.

6 May 2010

Neuroscientists investigate alcohol dependency, withdrawal in C. elegans worms

Drinking alcohol over a long period of time profoundly affects the brain, which adapts to the intoxicant and causes withdrawal symptoms when consumption stops.

6 May 2010

Experts unveil roadmap to improve health and health delivery in the U.S.

A Commission of national health care experts convened by the Center for the Study of the Presidency and Congress has unveiled a roadmap and integrated approach that will put "health" back into our nation's health care system as well as address key opportunities following passage of health care reform legislation.

6 May 2010

IBM embarks on multi-year research effort to better understand actions needed to improve human health

IBM today launched a multi-year research effort to connect and analyze enormous collections of data from a wide variety of sources in order to enable individuals, governments and businesses to better understand which actions to take to improve human health. The project will initially focus on solving the issue of childhood obesity.

6 May 2010

Chronic News and Research

Kent State University receives four-year, $2.7M grant to study cognitive status of heart failure patients

NewCardio to unveil patented CardioBip technology at HRS Annual Scientific Sessions

First 3-year results of world's largest temporomandibular joint disorder study reported at APS meeting

Cytori Therapeutics to initiate European medical device approval study for Celution System

New research examines coping and appraisal of disease-related pain

Inadvertent reprogramming of genes in peripheral nervous system may cause chronic pain

Meda acquires exclusive rights for use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals

Advances in genetic research could help develop personalized pain medications

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Hepcidin is found in various biological fluids, says new research

Medtronic initiates U.S. clinical trial of RestoreSensor neurostimulator in chronic pain patients

Telik first-quarter net loss decreases to $5.3 million

Study analyzes epidemiology of falls among elderly men

Tel Aviv researchers develop microscope-based cell scanner to speed research into fat-busting drugs

Australia’s first ever health policy for men

PurGenesis announces positive results from Phase I clinical trial of PUR0110 for ulcerative colitis

CombinatoRx reports $41.3M total revenue for first-quarter 2010

Neuroscientists investigate alcohol dependency, withdrawal in C. elegans worms

Experts unveil roadmap to improve health and health delivery in the U.S.

IBM embarks on multi-year research effort to better understand actions needed to improve human health

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News